If you’re being treated for primary hypothyroidism but are still experiencing symptoms, you might consider enrolling in the AVANTI Study of an investigational medication.
The AVANTI Study is comparing an investigational medicine to synthetic T4.
You may qualify for the AVANTI Study if you:-
Are 18 – 75 years of age-
Have been diagnosed with primaryhypothyroidism for at least 12 months-
Have been on continuous thyroidreplacement therapy with an FDAapproved dose of synthetic T4 for atleast 12 months, and at a stable dosefor at least 3 months
For more information contact Debbie Clark at 901-448-2676 or dmclark@uthsc.edu.